Ysios Capital targets $78.7 mln for Fund II
Ysios Capital said Wednesday it has begun seeking investors for its Ysios BioFund II, a 100 million Euro fund (US $78.7 million). Fund II will invest in life sciences companies with disruptive products, platforms or technologies in the pharmaceutical and medtech and diagnostics segments. Ysios BioFund I closed at 69 million Euro in 2008.
19 March 2014•2 mins read
